Using a genetic/clinical risk score to stop smoking (GeTSS): randomised controlled trial

Using a genetic/clinical risk score to stop smoking (GeTSS): randomised controlled trial

Abstract Background As genetic tests become cheaper, the possibility of their widespread availability must be considered. This study involves a risk score for lung cancer in smokers that is roughly 50% genetic (50% clinical criteria). The risk score has been shown to be effective as a smoking cessat...

Full description

Bibliographic Details
Main Authors: John A. A. Nichols, Paul Grob, Wendy Kite, Peter Williams, Simon de Lusignan
Format: Article
Language:English
Published: BMC 2017-10-01
Series:BMC Research Notes
Subjects:
Smoking cessation
Genetic testing
Lung neoplasms
Primary health care
Online Access:http://link.springer.com/article/10.1186/s13104-017-2831-2

Internet

http://link.springer.com/article/10.1186/s13104-017-2831-2

Similar Items